{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T13:33:56Z","timestamp":1775914436214,"version":"3.50.1"},"reference-count":228,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2022]]},"DOI":"10.2463\/mrms.rev.2020-0184","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T22:06:51Z","timestamp":1619647611000},"page":"212-234","source":"Crossref","is-referenced-by-count":17,"title":["State-of-the-art MR Imaging for Thoracic Diseases"],"prefix":"10.2463","volume":"21","author":[{"given":"Yumi","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"},{"name":"Joint Research Laboratory of Advanced Medical Imaging, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomu","family":"Hanamatsu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Obama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Iwase","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fukuba","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Murayama","sequence":"additional","affiliation":[{"name":"Joint Research Laboratory of Advanced Medical Imaging, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Hyogo Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Hyogo Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisanobu","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Osaka Police Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Toyama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fujita Health University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178:705\u2013713.","DOI":"10.1148\/radiology.178.3.1847239"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hatabu H, Ohno Y, Gefter WB, et al.; Fleischner society. Expanding applications of pulmonary MRI in the clinical evaluation of lung disorders: Fleischner society position paper. Radiology 2020; 297:286\u2013301.","DOI":"10.1148\/radiol.2020201138"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Schiebler ML, Parraga G, Gefter WB, et al. Synopsis from expanding applications of pulmonary MRI in the clinical evaluation of lung disorders: Fleischner society position paper. Chest 2021; 159:492\u2013495.","DOI":"10.1016\/j.chest.2020.09.075"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mayo JR. Thoracic magnetic resonance imaging: physics and pulse sequences. J Thorac Imaging 1993; 8:1\u201311.","DOI":"10.1097\/00005382-199324000-00002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kono M, Adachi S, Kusumoto M, et al. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer. J Thorac Imaging 1993; 8:18\u201326.","DOI":"10.1097\/00005382-199324000-00004"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kauczor HU, Kreitner KF. MRI of the pulmonary parenchyma. Eur Radiol 1999; 9:1755\u20131764.","DOI":"10.1007\/s003300050919"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hatabu H, Chen Q, Stock KW, et al. Fast magnetic resonance imaging of the lung. Eur J Radiol 1999; 29:114\u2013132.","DOI":"10.1016\/S0720-048X(98)00174-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Mayo JR. MR imaging of pulmonary parenchyma. Magn Reson Imaging Clin N Am 2000; 8:105\u2013123.","DOI":"10.1016\/S1064-9689(21)00044-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ohno Y, Chen Q, Hatabu H. Oxygen-enhanced magnetic resonance ventilation imaging of lung. Eur J Radiol 2001; 37:164\u2013171.","DOI":"10.1016\/S0720-048X(00)00299-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Salerno M, Altes TA, Mugler JP, et al. Hyperpolarized noble gas MR imaging of the lung: potential clinical applications. Eur J Radiol 2001; 40:33\u201344.","DOI":"10.1016\/S0720-048X(01)00347-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ohno Y, Sugimura K, Hatabu H. MR imaging of lung cancer. Eur J Radiol 2002; 44:172\u2013181.","DOI":"10.1016\/S0720-048X(02)00267-X"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ohno Y, Sugimura K, Hatabu H. Clinical oxygen-enhanced magnetic resonance imaging of the lung. Top Magn Reson Imaging 2003; 14:237\u2013243.","DOI":"10.1097\/00002142-200306000-00004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fain SB, Korosec FR, Holmes JH, et al. Functional lung imaging using hyperpolarized gas MRI. J Magn Reson Imaging 2007; 25:910\u2013923.","DOI":"10.1002\/jmri.20876"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sieren JC, Ohno Y, Koyama H, et al. Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging 2010; 32:1353\u20131369.","DOI":"10.1002\/jmri.22383"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ohno Y, Koyama H, Yoshikawa T, et al. Pulmonary magnetic resonance imaging for airway diseases. J Thorac Imaging 2011; 26:301\u2013316.","DOI":"10.1097\/RTI.0b013e3182242925"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Koyama H, Ohno Y, Seki S, et al. Magnetic resonance imaging for lung cancer. J Thorac Imaging 2013; 28:138\u2013150.","DOI":"10.1097\/RTI.0b013e31828d4234"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Liszewski MC, Hersman FW, Altes TA, et al. Magnetic resonance imaging of pediatric lung parenchyma, airways, vasculature, ventilation, and perfusion: state of the art. Radiol Clin North Am 2013; 51:555\u2013582.","DOI":"10.1016\/j.rcl.2013.04.004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ohno Y. New applications of magnetic resonance imaging for thoracic oncology. Semin Respir Crit Care Med 2014; 35:27\u201340.","DOI":"10.1055\/s-0033-1363449"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ohno Y, Nishio M, Koyama H, et al. Dynamic contrast-enhanced CT and MRI for pulmonary nodule assessment. AJR Am J Roentgenol 2014; 202:515\u2013529.","DOI":"10.2214\/AJR.13.11888"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kim HS, Lee KS, Ohno Y, et al. PET\/CT versus MRI for diagnosis, staging, and follow-up of lung cancer. J Magn Reson Imaging 2015; 42:247\u2013260.","DOI":"10.1002\/jmri.24776"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ohno Y, Koyama H, Yoshikawa T, et al. Lung cancer assessment using MR imaging: an update. Magn Reson Imaging Clin N Am 2015; 23:231\u2013244.","DOI":"10.1016\/j.mric.2015.01.012"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kruger SJ, Nagle SK, Couch MJ, et al. Functional imaging of the lungs with gas agents. J Magn Reson Imaging 2016; 43:295\u2013315.","DOI":"10.1002\/jmri.25002"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ohno Y, Koyama H, Yoshikawa T, et al. State-of-the-Art Imaging of the Lung for Connective Tissue Disease (CTD). Curr Rheumatol Rep 2015; 17:69.","DOI":"10.1007\/s11926-015-0546-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ohno Y, Koyama H, Lee HY, et al. Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)\/MRI for lung cancer staging. J Thorac Imaging 2016; 31:215\u2013227.","DOI":"10.1097\/RTI.0000000000000210"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ohno Y, Koyama H, Lee HY, et al. Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications. Diagn Interv Radiol 2016; 22:407\u2013421.","DOI":"10.5152\/dir.2016.16123"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Biederer J, Ohno Y, Hatabu H, et al. Screening for lung cancer: Does MRI have a role? Eur J Radiol 2017; 86:353\u2013360.","DOI":"10.1016\/j.ejrad.2016.09.016"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Johns CS, Swift AJ, Hughes PJC, et al. Pulmonary MR angiography and perfusion imaging-A review of methods and applications. Eur J Radiol 2017; 86:361\u2013370.","DOI":"10.1016\/j.ejrad.2016.10.003"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ohno Y, Yoshikawa T, Kishida Y, et al. Unenhanced and contrast-enhanced MR angiography and perfusion imaging for suspected pulmonary thromboembolism. AJR Am J Roentgenol 2017; 208:517\u2013530.","DOI":"10.2214\/AJR.16.17415"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ohno Y, Kauczor HU, Hatabu H, et al.; International Workshop for Pulmonary Functional Imaging (IWPFI). MRI for solitary pulmonary nodule and mass assessment: Current state of the art. J Magn Reson Imaging 2018; 47:1437\u20131458.","DOI":"10.1002\/jmri.26009"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ciliberto M, Kishida Y, Seki S, et al.. Update of MR Imaging for Evaluation of Lung Cancer. Radiol Clin North Am 2018; 56:437\u2013469.","DOI":"10.1016\/j.rcl.2018.01.005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Tsuchiya N, van Beek EJ, Ohno Y, et al. Magnetic resonance angiography for the primary diagnosis of pulmonary embolism: A review from the international workshop for pulmonary functional imaging. World J Radiol 2018; 10:52\u201364.","DOI":"10.4329\/wjr.v10.i6.52"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wielp\u00fctz MO, Triphan SMF, Ohno Y, et al. Outracing lung signal decay \u2013 potential of ultrashort echo time MRI. Rofo 2019; 191:415\u2013423.","DOI":"10.1055\/a-0715-2246"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Cutillo AG, Morris AH, Blatter DD, et al. Determination of lung water content and distribution by nuclear magnetic resonance. J Appl Physiol Respir Environ Exerc Physiol 1984; 57:583\u2013588.","DOI":"10.1152\/jappl.1984.57.2.583"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Cutillo AG, Morris AH, Ailion DC, et al. Determination of lung water content and distribution by nuclear magnetic resonance imaging. J Thorac Imaging 1986; 1:39\u201351.","DOI":"10.1097\/00005382-198607000-00007"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Cutillo AG, Ganesan K, Ailion DC, et al. Alveolar air-tissue interface and nuclear magnetic resonance behavior of lung. J Appl Physiol (1985) 1991; 70:2145\u20132154.","DOI":"10.1152\/jappl.1991.70.5.2145"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Mayo JR, MacKay A, M\u00fcller NL. MR imaging of the lungs: value of short TE spin-echo pulse sequences. AJR Am J Roentgenol 1992; 159:951\u2013956.","DOI":"10.2214\/ajr.159.5.1414805"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Alsop DC, Hatabu H, Bonnet M, et al. Multi-slice, breathhold imaging of the lung with submillisecond echo times. Magn Reson Med 1995; 33:678\u2013682.","DOI":"10.1002\/mrm.1910330513"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Hatabu H, Gaa J, Tadamura E, et al. MR imaging of pulmonary parenchyma with a half-Fourier single-shot turbo spin-echo (HASTE) sequence. Eur J Radiol 1999; 29:152\u2013159.","DOI":"10.1016\/S0720-048X(98)00167-3"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Hatabu H, Alsop DC, Listerud J, et al. T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. Eur J Radiol 1999; 29:245\u2013252.","DOI":"10.1016\/S0720-048X(98)00169-7"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ohno Y, Oshio K, Uematsu H, et al. Single-shot half-Fourier RARE sequence with ultra-short inter-echo spacing for lung imaging. J Magn Reson Imaging 2004; 20:336\u2013339.","DOI":"10.1002\/jmri.20107"},{"key":"41","unstructured":"41. Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22:275\u2013282."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Lenz C, Klarh\u00f6fer M, Scheffler K, et al. Assessing extracranial tumors using diffusion-weighted whole-body MRI. Z Med Phys 2011; 21:79\u201390.","DOI":"10.1016\/j.zemedi.2010.06.004"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Gibiino F, Sacolick L, Menini A, et al. Free-breathing, zero-TE MR lung imaging. MAGMA 2015; 28:207\u2013215.","DOI":"10.1007\/s10334-014-0459-y"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Ohno Y, Koyama H, Yoshikawa T, et al. Pulmonary high-resolution ultrashort TE MR imaging: Comparison with thin-section standard- and low-dose computed tomography for the assessment of pulmonary parenchyma diseases. J Magn Reson Imaging 2016; 43:512\u2013532.","DOI":"10.1002\/jmri.25008"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ohno Y, Koyama H, Yoshikawa T, et al. Standard-, reduced-, and no-dose thin-section radiologic examinations: comparison of capability for nodule detection and nodule type assessment in patients suspected of having pulmonary nodules. Radiology 2017; 284:562\u2013573.","DOI":"10.1148\/radiol.2017161037"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Wielp\u00fctz MO, Lee HY, Koyama H, et al. Morphologic characterization of pulmonary nodules with ultrashort TE MRI at 3T. AJR Am J Roentgenol 2018; 210:1216\u20131225.","DOI":"10.2214\/AJR.17.18961"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Ohno Y, Yui M, Chen Y, et al. Gadolinium-based blood volume mapping from MRI with ultrashort TE versus CT and SPECT for predicting postoperative lung function in patients with non-small cell lung cancer. AJR Am J Roentgenol 2019; 212:57\u201366.","DOI":"10.2214\/AJR.18.20095"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Zeng F, Nogami M, Ueno YR, et al. Diagnostic performance of zero-TE lung MR imaging in FDG PET\/MRI for pulmonary malignancies. Eur Radiol 2020; 30:4995\u20135003.","DOI":"10.1007\/s00330-020-06848-z"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Takahashi M, Togao O, Obara M, et al. Ultra-short echo time (UTE) MR imaging of the lung: comparison between normal and emphysematous lungs in mutant mice. J Magn Reson Imaging 2010; 32:326\u2013333.","DOI":"10.1002\/jmri.22267"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Togao O, Ohno Y, Dimitrov I, et al. Ventilation\/perfusion imaging of the lung using ultra-short echo time (UTE) MRI in an animal model of pulmonary embolism. J Magn Reson Imaging 2011; 34:539\u2013546.","DOI":"10.1002\/jmri.22645"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Ohno Y, Koyama H, Yoshikawa T, et al. T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers. AJR Am J Roentgenol 2011; 197:W279\u2013285.","DOI":"10.2214\/AJR.10.5350"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Ohno Y, Nishio M, Koyama H, et al. Pulmonary MR imaging with ultra-short TEs: utility for disease severity assessment of connective tissue disease patients. Eur J Radiol 2013; 82:1359\u20131365.","DOI":"10.1016\/j.ejrad.2013.02.031"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Ohno Y, Nishio M, Koyama H, et al. Pulmonary 3 T MRI with ultrashort TEs: influence of ultrashort echo time interval on pulmonary functional and clinical stage assessments of smokers. J Magn Reson Imaging 2014; 39:988\u2013997.","DOI":"10.1002\/jmri.24232"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Ohno Y, Koyama H, Nogami M, et al. Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging 2007; 26:498\u2013509.","DOI":"10.1002\/jmri.21031"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Yi CA, Shin KM, Lee KS, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET\/CT versus 3.0-T whole-body MR imaging. Radiology 2008; 248: 632\u2013642.","DOI":"10.1148\/radiol.2482071822"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment\u2014utility for whole-body diffusion-weighted imaging compared with integrated FDG PET\/CT. Radiology 2008; 248:643\u2013654.","DOI":"10.1148\/radiol.2482072039"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Takenaka D, Ohno Y, Matsumoto K, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET\/CT, and bone scintigraphy. J Magn Reson Imaging 2009; 30:298\u2013308.","DOI":"10.1002\/jmri.21858"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Ohno Y, Nishio M, Koyama H, et al. Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET\/CT and conventional examination for assessment of recurrence in NSCLC patients. Eur J Radiol 2013; 82:2018\u20132027.","DOI":"10.1016\/j.ejrad.2013.07.016"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Yi CA, Lee KS, Lee HY, et al. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial. Cancer 2013; 119:1784\u20131791.","DOI":"10.1002\/cncr.28000"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Ohno Y, Koyama H, Yoshikawa T, et al. Three-way comparison of whole-body MR, Coregistered whole-body FDG PET\/MR, and integrated whole-body FDG PET\/CT imaging: TNM and stage assessment capability for non-small cell lung cancer patients. Radiology 2015; 275:849\u2013861.","DOI":"10.1148\/radiol.14140936"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Ohno Y, Yoshikawa T, Kishida Y, et al. Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non-small cell lung cancer. J Magn Reson Imaging 2017; 46:1707\u20131717.","DOI":"10.1002\/jmri.25726"},{"key":"62","doi-asserted-by":"publisher","unstructured":"62. Ohno Y, Kishida Y, Seki S, et al. Comparison of interobserver agreement and diagnostic accuracy for IASLC\/ITMIG thymic epithelial tumor staging among co-registered FDG-PET\/MRI, whole-body MRI, integrated FDG-PET\/CT, and conventional imaging examination with and without contrast media administrations. Acad Radiol 2018 Feb 1. doi: 10.1016\/j.acra.2017.12.016. [Epub ahead of print]","DOI":"10.1016\/j.acra.2017.12.016"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Ohno Y, Yui M, Aoyagi K, et al. Whole-Body MRI: comparison of its capability for TNM staging of malignant pleural mesothelioma with that of coregistered PET\/MRI, integrated FDG PET\/CT, and conventional imaging. AJR Am J Roentgenol 2019; 212:311\u2013319.","DOI":"10.2214\/AJR.18.20111"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Ohno Y, Takeshi Y, Takenaka D, et al. Comparison of diagnostic accuracy for TNM stage among whole-body MRI and coregistered PET\/MRI Using 1.5-T and 3-T MRI systems and integrated PET\/CT for non-small cell lung cancer. AJR Am J Roentgenol 2020; 215:1191\u20131198.","DOI":"10.2214\/AJR.19.22565"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Vogt FM, Herborn CU, Hunold P, et al. HASTE MRI versus chest radiography in the detection of pulmonary nodules: comparison with MDCT. AJR Am J Roentgenol 2004; 183:71\u201378.","DOI":"10.2214\/ajr.183.1.1830071"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Bruegel M, Gaa J, Woertler K, et al. MRI of the lung: value of different turbo spin-echo, single-shot turbo spin-echo, and 3D gradient-echo pulse sequences for the detection of pulmonary metastases. J Magn Reson Imaging 2007; 25:73\u201381.","DOI":"10.1002\/jmri.20824"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Yi CA, Jeon TY, Lee KS, et al. 3-T MRI: usefulness for evaluating primary lung cancer and small nodules in lobes not containing primary tumors. AJR Am J Roentgenol 2007; 189:386\u2013392.","DOI":"10.2214\/AJR.07.2082"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Koyama H, Ohno Y, Kono A, et al. Quantitative and qualitative assessment of non-contrast-enhanced pulmonary MR imaging for management of pulmonary nodules in 161 subjects. Eur Radiol 2008; 18:2120\u20132131.","DOI":"10.1007\/s00330-008-1001-2"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Frericks BB, Meyer BC, Martus P, et al. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT). J Magn Reson Imaging 2008; 27:538\u2013545.","DOI":"10.1002\/jmri.21218"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Cieszanowski A, Lisowska A, Dabrowska M, et al. MR imaging of pulmonary nodules: detection rate and accuracy of size estimation in comparison to computed tomography. PLoS One 2016; 11:e0156272.","DOI":"10.1371\/journal.pone.0156272"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Burris NS, Johnson KM, Larson PE, et al. Detection of small pulmonary nodules with ultrashort echo time sequences in oncology patients by using a PET\/MR system. Radiology 2016; 278:239\u2013246.","DOI":"10.1148\/radiol.2015150489"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Li B, Li Q, Chen C, et al. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses. Acad Radiol 2014; 21:21\u201329.","DOI":"10.1016\/j.acra.2013.09.019"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Basso Dias A, Zanon M, Altmayer S, et al. Fluorine 18-FDG PET\/CT and diffusion-weighted MRI for malignant versus benign pulmonary lesions: a meta-analysis. Radiology 2019; 290:525\u2013534.","DOI":"10.1148\/radiol.2018181159"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Usuda K, Sagawa M, Motono N, et al. Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses: comparison with positron emission tomography. Asian Pac J Cancer Prev 2014; 15:4629\u20134635.","DOI":"10.7314\/APJCP.2014.15.11.4629"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Koyama H, Ohno Y, Seki S, et al. Value of diffusion-weighted MR imaging using various parameters for assessment and characterization of solitary pulmonary nodules. Eur J Radiol 2015; 84:509\u2013515.","DOI":"10.1016\/j.ejrad.2014.11.024"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Ohno Y, Kishida Y, Seki S, et al. Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: comparison with diffusion-weighted imaging and FDG-PET\/CT. J Magn Reson Imaging 2018; 47:1013\u20131021.","DOI":"10.1002\/jmri.25832"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Hittmair K, Eckersberger F, Klepetko W, et al. Evaluation of solitary pulmonary nodules with dynamic contrast-enhanced MR imaging\u2014a promising technique. Magn Reson Imaging 1995; 13:923\u2013933.","DOI":"10.1016\/0730-725X(95)02010-Q"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. G\u00fcckel C, Schnabel K, Deimling M, et al. Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology 1996; 200:681\u2013686.","DOI":"10.1148\/radiology.200.3.8756914"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Ohno Y, Hatabu H, Takenaka D, et al. Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience. Radiology 2002; 224:503\u2013511.","DOI":"10.1148\/radiol.2242010992"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Schaefer JF, Vollmar J, Schick F, et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging\u2014perfusion differences in malignant and benign lesions. Radiology 2004; 232:544\u2013553.","DOI":"10.1148\/radiol.2322030515"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Kono R, Fujimoto K, Terasaki H, et al. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions. AJR Am J Roentgenol 2007; 188:26\u201336.","DOI":"10.2214\/AJR.05.1446"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Ohno Y, Koyama H, Takenaka D, et al. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)\/CT: comparative study of capability for management of pulmonary nodules. J Magn Reson Imaging 2008; 27:1284\u20131295.","DOI":"10.1002\/jmri.21348"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Zou Y, Zhang M, Wang Q, et al. Quantitative investigation of solitary pulmonary nodules: dynamic contrast-enhanced MRI and histopathologic analysis. AJR Am J Roentgenol 2008; 191:252\u2013259.","DOI":"10.2214\/AJR.07.2284"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Coolen J, Vansteenkiste J, De Keyzer F, et al. Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging. Eur Radiol 2014; 24:531\u2013541.","DOI":"10.1007\/s00330-013-3053-1"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Ohno Y, Nishio M, Koyama H, et al. Solitary pulmonary nodules: comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET\/CT. Radiology 2015; 274:563\u2013575.","DOI":"10.1148\/radiol.14132289"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Ohno Y, Fujisawa Y, Yui M, et al. Solitary pulmonary nodule: comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET\/CT. Eur J Radiol 2019; 115:22\u201330.","DOI":"10.1016\/j.ejrad.2019.03.018"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Cronin P, Dwamena BA, Kelly AM, et al. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology 2008; 246:772\u2013782.","DOI":"10.1148\/radiol.2463062148"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Sakai S, Murayama S, Murakami J, et al. Bronchogenic carcinoma invasion of the chest wall: evaluation with dynamic cine MRI during breathing. J Comput Assist Tomogr 1997; 21:595\u2013600.","DOI":"10.1097\/00004728-199707000-00013"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Ohno Y, Adachi S, Motoyama A, et al. Multiphase ECG-triggered 3D contrast-enhanced MR angiography: utility for evaluation of hilar and mediastinal invasion of bronchogenic carcinoma. J Magn Reson Imaging 2001; 13:215\u2013224.","DOI":"10.1002\/1522-2586(200102)13:2<215::AID-JMRI1032>3.0.CO;2-2"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Tang W, Wu N, OuYang H, et al. The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI. Cancer Imaging 2015; 15:14.","DOI":"10.1186\/s40644-015-0050-4"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Takenaka D, Ohno Y, Hatabu H, et al. Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol 2002; 44:216\u2013224.","DOI":"10.1016\/S0720-048X(02)00271-1"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Ohno Y, Hatabu H, Takenaka D, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 2004; 231:872\u2013879.","DOI":"10.1148\/radiol.2313030103"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Ohno Y, Koyama H, Nogami M, et al. STIR turbo SE MR imaging vs. coregistered FDG-PET\/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. J Magn Reson Imaging 2007; 26:1071\u20131080.","DOI":"10.1002\/jmri.21106"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Hasegawa I, Boiselle PM, Kuwabara K, et al. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging. J Thorac Imaging 2008; 23:157\u2013161.","DOI":"10.1097\/RTI.0b013e318166d2f5"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Nomori H, Mori T, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg 2008; 135:816\u2013822.","DOI":"10.1016\/j.jtcvs.2007.10.035"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Morikawa M, Demura Y, Ishizaki T, et al. The effectiveness of <sup>18<\/sup>F-FDG PET\/CT combined with STIR MRI for diagnosing nodal involvement in the thorax. J Nucl Med 2009; 50:81\u201387.","DOI":"10.2967\/jnumed.108.056408"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Nakayama J, Miyasaka K, Omatsu T, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010; 34:1\u20138.","DOI":"10.1097\/RCT.0b013e3181a9cc07"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Usuda K, Zhao XT, Sagawa M, et al. Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers. Ann Thorac Surg 2011; 91:1689\u20131695.","DOI":"10.1016\/j.athoracsur.2011.02.037"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Ohno Y, Koyama H, Yoshikawa T, et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET\/CT. Radiology 2011; 261:605\u2013615.","DOI":"10.1148\/radiol.11110281"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Ohno Y, Koyama H, Yoshikawa T, et al. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET\/CT for non-small cell lung cancer patients. Eur J Radiol 2015; 84:2321\u20132331.","DOI":"10.1016\/j.ejrad.2015.07.019"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Usuda K, Maeda S, Motono N, et al. Diagnostic performance of diffusion-weighted imaging for multiple hilar and mediastinal lymph nodes with FDG accumulation. Asian Pac J Cancer Prev 2015; 16:6401\u20136406.","DOI":"10.7314\/APJCP.2015.16.15.6401"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Nomori H, Cong Y, Sugimura H, et al. Diffusion-weighted imaging can correctly identify false-positive lymph nodes on positron emission tomography in non-small cell lung cancer. Surg Today 2016; 46:1146\u20131151.","DOI":"10.1007\/s00595-015-1285-1"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Peerlings J, Troost EG, Nelemans PJ, et al. The diagnostic value of MR imaging in determining the lymph node status of patients with non-small cell lung cancer: a meta-analysis. Radiology 2016; 281:86\u201398.","DOI":"10.1148\/radiol.2016151631"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Sommer G, Wiese M, Winter L, et al. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography\/computed tomography. Eur Radiol 2012; 22:2859\u20132867.","DOI":"10.1007\/s00330-012-2542-y"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Schaarschmidt BM, Grueneisen J, Metzenmacher M, et al. Thoracic staging with <sup>18<\/sup>F-FDG PET\/MR in non-small cell lung cancer \u2013 does it change therapeutic decisions in comparison to <sup>18<\/sup>F-FDG PET\/CT? Eur Radiol 2017; 27:681\u2013688.","DOI":"10.1007\/s00330-016-4397-0"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Lee SM, Goo JM, Park CM, et al. Preoperative staging of non-small cell lung cancer: prospective comparison of PET\/MR and PET\/CT. Eur Radiol 2016; 26:3850\u20133857.","DOI":"10.1007\/s00330-016-4255-0"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Takahashi K, Al-Janabi NJ. Computed tomography and magnetic resonance imaging of mediastinal tumors. J Magn Reson Imaging 2010; 32:1325\u20131339.","DOI":"10.1002\/jmri.22377"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108. Inaoka T, Takahashi K, Iwata K, Nagasawa K, Shuke N, Aburano T., et al. Evaluation of normal fatty replacement of the thymus with chemical-shift MR imaging for identification of the normal thymus. J Magn Reson Imaging 2005; 22:341\u2013346.","DOI":"10.1002\/jmri.20407"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. Linegar AG, Odell JA, Fennell WM, et al. Massive thymic hyperplasia. Ann Thorac Surg 1993; 55:1197\u20131201.","DOI":"10.1016\/0003-4975(93)90033-E"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. Takahashi K, Inaoka T, Murakami N, et al. Characterization of the normal and hyperplastic thymus on chemical-shift MR imaging. AJR Am J Roentgenol 2003; 180:1265\u20131269.","DOI":"10.2214\/ajr.180.5.1801265"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Inaoka T, Takahashi K, Mineta M, et al. Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology 2007; 243:869\u2013876.","DOI":"10.1148\/radiol.2433060797"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Seki S, Koyama H, Ohno Y, et al. Diffusion-weighted MR imaging vs. multi-detector row CT: direct comparison of capability for assessment of management needs for anterior mediastinal solitary tumors. Eur J Radiol 2014; 83:835\u2013842.","DOI":"10.1016\/j.ejrad.2014.01.005"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Yabuuchi H, Matsuo Y, Abe K, et al. Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET\/CT. Clin Radiol 2015; 70:1289\u20131298.","DOI":"10.1016\/j.crad.2015.07.004"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Falaschi F, Battolla L, Mascalchi M, et al. Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am J Roentgenol 1996; 166:963\u2013968.","DOI":"10.2214\/ajr.166.4.8610582"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353:1591\u20131603.","DOI":"10.1056\/NEJMra050152"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116. Curran D, Sahmoud T, Therasse P, et al. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 1998; 16:145\u2013152.","DOI":"10.1200\/JCO.1998.16.1.145"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117. Helm EJ, Matin TN, Gleeson FV. Imaging of the pleura. J Magn Reson Imaging 2010; 32:1275\u20131286.","DOI":"10.1002\/jmri.22372"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118. Hierholzer J, Luo L, Bittner RC, et al. MRI and CT in the differential diagnosis of pleural disease. Chest 2000; 118:604\u2013609.","DOI":"10.1378\/chest.118.3.604"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119. Heelan RT, Rusch VW, Begg CB, et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999; 172:1039\u20131047.","DOI":"10.2214\/ajr.172.4.10587144"},{"key":"120","doi-asserted-by":"crossref","unstructured":"120. Patz EF, Shaffer K, Piwnica-Worms DR, et al. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol 1992; 159:961\u2013966.","DOI":"10.2214\/ajr.159.5.1414807"},{"key":"121","doi-asserted-by":"crossref","unstructured":"121. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999; 117:54\u201363; discussion 63-65.","DOI":"10.1016\/S0022-5223(99)70469-1"},{"key":"122","doi-asserted-by":"crossref","unstructured":"122. Gill RR, Umeoka S, Mamata H, et al. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol 2010; 195:W125\u2013130.","DOI":"10.2214\/AJR.09.3519"},{"key":"123","doi-asserted-by":"crossref","unstructured":"123. Murphy DJ, Mak SM, Mallia A, et al. Loco-regional staging of malignant pleural mesothelioma by integrated <sup>18<\/sup>F-FDG PET\/MRI. Eur J Radiol 2019; 115:46\u201352.","DOI":"10.1016\/j.ejrad.2019.04.003"},{"key":"124","doi-asserted-by":"crossref","unstructured":"124. Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62(25 Suppl):D42\u201350.","DOI":"10.1016\/j.jacc.2013.10.032"},{"key":"125","doi-asserted-by":"crossref","unstructured":"125. Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53:1801913.","DOI":"10.1183\/13993003.01913-2018"},{"key":"126","doi-asserted-by":"crossref","unstructured":"126. Gali\u00e8 N, Humbert M, Vachiery JL, et al. ESC Scientific Document Group. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67\u2013119.","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"127","doi-asserted-by":"crossref","unstructured":"127. Kiely DG, Levin D, Hassoun P, et al. EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulm Circ 2019; 9:2045894019841990.","DOI":"10.1177\/2045894019841990"},{"key":"128","doi-asserted-by":"crossref","unstructured":"128. Rajaram S, Swift AJ, Telfer A, et al. 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. Thorax 2013; 68:677\u2013678.","DOI":"10.1136\/thoraxjnl-2012-203020"},{"key":"129","doi-asserted-by":"crossref","unstructured":"129. Johns CS, Swift AJ, Rajaram S, et al. Lung perfusion: MRI vs. SPECT for screening in suspected chronic thromboembolic pulmonary hypertension. J Magn Reson Imaging 2017; 46:1693\u20131697.","DOI":"10.1002\/jmri.25714"},{"key":"130","doi-asserted-by":"crossref","unstructured":"130. Humbert M, Lau EM, Montani D, et al. Advances in therapeutic interventions for patients with pulmonary arterial hypertension. Circulation 2014; 130:2189\u20132208.","DOI":"10.1161\/CIRCULATIONAHA.114.006974"},{"key":"131","doi-asserted-by":"crossref","unstructured":"131. Swift AJ, Telfer A, Rajaram S, et al. Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension. Pulm Circ 2014; 4:61\u201370.","DOI":"10.1086\/674882"},{"key":"132","doi-asserted-by":"crossref","unstructured":"132. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007; 28:1250\u20131257.","DOI":"10.1093\/eurheartj\/ehl477"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133. van Wolferen SA, van de Veerdonk MC, Mauritz GJ, et al. Clinically significant change in stroke volume in pulmonary hypertension. Chest 2011; 139:1003\u20131009.","DOI":"10.1378\/chest.10-1066"},{"key":"134","doi-asserted-by":"crossref","unstructured":"134. van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011; 58:2511\u20132519.","DOI":"10.1016\/j.jacc.2011.06.068"},{"key":"135","doi-asserted-by":"crossref","unstructured":"135. Peacock AJ, Crawley S, McLure L, et al. Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. Circ Cardiovasc Imaging 2014; 7:107\u2013114.","DOI":"10.1161\/CIRCIMAGING.113.000629"},{"key":"136","doi-asserted-by":"crossref","unstructured":"136. Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging 2004; 20:353\u2013365.","DOI":"10.1002\/jmri.20137"},{"key":"137","doi-asserted-by":"crossref","unstructured":"137. Ohno Y, Hatabu H, Murase K, et al. Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. AJR Am J Roentgenol 2007; 188:48\u201356.","DOI":"10.2214\/AJR.05.0135"},{"key":"138","doi-asserted-by":"crossref","unstructured":"138. Ohno Y, Koyama H, Nogami M, et al. Dynamic perfusion MRI: capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease. J Magn Reson Imaging 2008; 28:887\u2013899.","DOI":"10.1002\/jmri.21550"},{"key":"139","doi-asserted-by":"crossref","unstructured":"139. Ohno Y, Koyama H, Yoshikawa T, et al. Contrast-enhanced multidetector-row computed tomography vs. Time-resolved magnetic resonance angiography vs. contrast-enhanced perfusion MRI: assessment of treatment response by patients with inoperable chronic thromboembolic pulmonary hypertension. J Magn Reson Imaging 2012; 36:612\u2013623.","DOI":"10.1002\/jmri.23680"},{"key":"140","doi-asserted-by":"crossref","unstructured":"140. Rajaram S, Swift AJ, Capener D, et al. Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 2012; 22:310\u2013317.","DOI":"10.1007\/s00330-011-2252-x"},{"key":"141","doi-asserted-by":"crossref","unstructured":"141. Swift AJ, Rajaram S, Condliffe R, et al. Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension. Invest Radiol 2012; 47:571\u2013577.","DOI":"10.1097\/RLI.0b013e31826c4341"},{"key":"142","doi-asserted-by":"crossref","unstructured":"142. Gan CT, Lankhaar JW, Westerhof N, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest 2007; 132:1906\u20131912.","DOI":"10.1378\/chest.07-1246"},{"key":"143","doi-asserted-by":"crossref","unstructured":"143. Swift AJ, Capener D, Johns C, et al. Magnetic resonance imaging in the prognostic evaluation of patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2017; 196:228\u2013239.","DOI":"10.1164\/rccm.201611-2365OC"},{"key":"144","doi-asserted-by":"crossref","unstructured":"144. Baggen VJ, Leiner T, Post MC, et al. Cardiac magnetic resonance findings predicting mortality in patients with pulmonary arterial hypertension: a systematic review and meta-analysis. Eur Radiol 2016; 26:3771\u20133780.","DOI":"10.1007\/s00330-016-4217-6"},{"key":"145","doi-asserted-by":"crossref","unstructured":"145. de Siqueira ME, Pozo E, Fernandes VR, et al. Characterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking. J Cardiovasc Magn Reson 2016; 18:39.","DOI":"10.1186\/s12968-016-0258-x"},{"key":"146","doi-asserted-by":"crossref","unstructured":"146. Ray JC, Burger C, Mergo P, et al. Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension. Int J Cardiovasc Imaging 2019; 35:1881\u20131892.","DOI":"10.1007\/s10554-018-1397-y"},{"key":"147","doi-asserted-by":"crossref","unstructured":"147. Tello K, Dalmer A, Vanderpool R, et al. Right ventricular function correlates of right atrial strain in pulmonary hypertension: a combined cardiac magnetic resonance and conductance catheter study. Am J Physiol Heart Circ Physiol 2020; 318:H156\u2013H164.","DOI":"10.1152\/ajpheart.00485.2019"},{"key":"148","doi-asserted-by":"crossref","unstructured":"148. Sheh SH, Bellin E, Freeman KD, et al. Pulmonary embolism diagnosis and mortality with pulmonary CT angiography versus ventilation-perfusion scintigraphy: evidence of overdiagnosis with CT? AJR Am J Roentgenol 2012; 198:1340\u20131345.","DOI":"10.2214\/AJR.11.6426"},{"key":"149","doi-asserted-by":"crossref","unstructured":"149. Sikkens JJ, Beekman DG, Thijs A, et al. How much overtesting is needed to safely exclude a diagnosis? a different perspective on triage testing using Bayes\u2019 theorem. PLoS One 2016; 11:e0150891.","DOI":"10.1371\/journal.pone.0150891"},{"key":"150","doi-asserted-by":"crossref","unstructured":"150. Ohno Y, Kawamitsu H, Higashino T, et al. Time-resolved contrast-enhanced pulmonary MR angiography using sensitivity encoding (SENSE). J Magn Reson Imaging 2003; 17:330\u2013336.","DOI":"10.1002\/jmri.10261"},{"key":"151","doi-asserted-by":"crossref","unstructured":"151. Ohno Y, Higashino T, Takenaka D, et al. MR angiography with sensitivity encoding (SENSE) for suspected pulmonary embolism: comparison with MDCT and ventilation-perfusion scintigraphy. AJR Am J Roentgenol 2004; 183:91\u201398.","DOI":"10.2214\/ajr.183.1.1830091"},{"key":"152","doi-asserted-by":"crossref","unstructured":"152. Kluge A, Luboldt W, Bachmann G. Acute pulmonary embolism to the subsegmental level: diagnostic accuracy of three MRI techniques compared with 16-MDCT. AJR Am J Roentgenol 2006; 187:W7\u201314.","DOI":"10.2214\/AJR.04.1814"},{"key":"153","doi-asserted-by":"crossref","unstructured":"153. Meaney JF, Weg JG, Chenevert TL, et al. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 1997; 336:1422\u20131427.","DOI":"10.1056\/NEJM199705153362004"},{"key":"154","doi-asserted-by":"crossref","unstructured":"154. Gupta A, Frazer CK, Ferguson JM, et al. Acute pulmonary embolism: diagnosis with MR angiography. Radiology 1999; 210:353\u2013359.","DOI":"10.1148\/radiology.210.2.r99fe53353"},{"key":"155","doi-asserted-by":"crossref","unstructured":"155. Oudkerk M, van Beek EJ, Wielopolski P, et al. Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 2002; 359:1643\u20131647.","DOI":"10.1016\/S0140-6736(02)08596-3"},{"key":"156","doi-asserted-by":"crossref","unstructured":"156. Stein PD, Chenevert TL, Fowler SE, et al. PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis III) Investigators. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 2010; 152:434-443, W142\u2013143.","DOI":"10.7326\/0003-4819-152-7-201004060-00008"},{"key":"157","doi-asserted-by":"crossref","unstructured":"157. Rajaram S, Swift AJ, Capener D, et al. Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT. Radiology 2012; 263:569\u2013577.","DOI":"10.1148\/radiol.12110990"},{"key":"158","doi-asserted-by":"crossref","unstructured":"158. Johnson KM, Fain SB, Schiebler ML, et al. Optimized 3D ultrashort echo time pulmonary MRI. Magn Reson Med 2013; 70:1241\u20131250.","DOI":"10.1002\/mrm.24570"},{"key":"159","doi-asserted-by":"crossref","unstructured":"159. Dournes G, Grodzki D, Macey J, et al. Quiet submillimeter MR imaging of the lung is feasible with a PETRA sequence at 1.5 T. Radiology 2015; 276:258\u2013265.","DOI":"10.1148\/radiol.15141655"},{"key":"160","doi-asserted-by":"crossref","unstructured":"160. Galb\u00e1n CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 2012; 18:1711\u20131715.","DOI":"10.1038\/nm.2971"},{"key":"161","doi-asserted-by":"crossref","unstructured":"161. Smith BM, Hoffman EA, Rabinowitz D, et al. Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax 2014; 69:987\u2013996.","DOI":"10.1136\/thoraxjnl-2014-205160"},{"key":"162","doi-asserted-by":"crossref","unstructured":"162. Regan EA, Lynch DA, Curran-Everett D, et al. Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and Radiologic Disease in Smokers With Normal Spirometry. JAMA Intern Med 2015; 175:1539\u20131549.","DOI":"10.1001\/jamainternmed.2015.2735"},{"key":"163","doi-asserted-by":"crossref","unstructured":"163. Putman RK, Hatabu H, Araki T, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators; COPDGene Investigators. Association Between Interstitial Lung Abnormalities and All-Cause Mortality. JAMA 2016; 315:672\u2013681.","DOI":"10.1001\/jama.2016.0518"},{"key":"164","doi-asserted-by":"crossref","unstructured":"164. Sack CS, Doney BC, Podolanczuk AJ, et al. Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies. Am J Respir Crit Care Med 2017; 196:1031\u20131039.","DOI":"10.1164\/rccm.201612-2431OC"},{"key":"165","doi-asserted-by":"crossref","unstructured":"165. de Lange EE, Mugler JP, Brookeman JR, et al. Lung air spaces: MR imaging evaluation with hyperpolarized <sup>3<\/sup>He gas. Radiology 1999; 210:851\u2013857.","DOI":"10.1148\/radiology.210.3.r99fe08851"},{"key":"166","doi-asserted-by":"crossref","unstructured":"166. Salerno M, de Lange EE, Altes TA, et al. Emphysema: hyperpolarized helium 3 diffusion MR imaging of the lungs compared with spirometric indexes\u2013initial experience. Radiology 2002; 222:252\u2013260.","DOI":"10.1148\/radiol.2221001834"},{"key":"167","doi-asserted-by":"crossref","unstructured":"167. Fain SB, Panth SR, Evans MD, et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology 2006; 239:875\u2013883.","DOI":"10.1148\/radiol.2393050111"},{"key":"168","doi-asserted-by":"crossref","unstructured":"168. Quirk JD, Lutey BA, Gierada DS, et al. In vivo detection of acinar microstructural changes in early emphysema with <sup>3<\/sup>He lung morphometry. Radiology 2011; 260:866\u2013874.","DOI":"10.1148\/radiol.11102226"},{"key":"169","doi-asserted-by":"crossref","unstructured":"169. Kirby M, Mathew L, Heydarian M, et al. Chronic obstructive pulmonary disease: quantification of bronchodilator effects by using hyperpolarized \u00b3He MR imaging. Radiology 2011; 261:283\u2013292.","DOI":"10.1148\/radiol.11110403"},{"key":"170","doi-asserted-by":"crossref","unstructured":"170. Kirby M, Svenningsen S, Owrangi A, et al. Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology 2012; 265:600\u2013610.","DOI":"10.1148\/radiol.12120485"},{"key":"171","doi-asserted-by":"crossref","unstructured":"171. Kirby M, Pike D, Coxson HO, et al. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. Radiology 2014; 273:887\u2013896.","DOI":"10.1148\/radiol.14140161"},{"key":"172","doi-asserted-by":"crossref","unstructured":"172. Kirby M, Pike D, Sin DD, et al. COPD: do imaging measurements of emphysema and airway disease explain symptoms and exercise capacity? Radiology 2015; 277:872\u2013880.","DOI":"10.1148\/radiol.2015150037"},{"key":"173","doi-asserted-by":"crossref","unstructured":"173. Westcott A, Capaldi DPI, McCormack DG, et al. Chronic obstructive pulmonary disease: thoracic CT texture analysis and machine learning to predict pulmonary ventilation. Radiology 2019; 293:676\u2013684.","DOI":"10.1148\/radiol.2019190450"},{"key":"174","doi-asserted-by":"crossref","unstructured":"174. MacNeil JL, Capaldi DPI, Westcott AR, et al. Pulmonary imaging phenotypes of chronic obstructive pulmonary disease using multiparametric response maps. Radiology 2020; 295:227\u2013236.","DOI":"10.1148\/radiol.2020191735"},{"key":"175","doi-asserted-by":"crossref","unstructured":"175. Tafti S, Garrison WJ, Mugler JP, et al. Emphysema index based on hyperpolarized <sup>3<\/sup>He or <sup>129<\/sup>Xe diffusion MRI: performance and comparison with quantitative CT and pulmonary function tests. Radiology 2020; 297:201\u2013210.","DOI":"10.1148\/radiol.2020192804"},{"key":"176","doi-asserted-by":"crossref","unstructured":"176. Ohno Y, Hatabu H, Takenaka D, et al. Dynamic oxygen-enhanced MRI reflects diffusing capacity of the lung. Magn Reson Med 2002; 47:1139\u20131144.","DOI":"10.1002\/mrm.10168"},{"key":"177","doi-asserted-by":"crossref","unstructured":"177. Ohno Y, Hatabu H, Higashino T, et al. Oxygen-enhanced MR imaging: correlation with postsurgical lung function in patients with lung cancer. Radiology 2005; 236:704\u2013711.","DOI":"10.1148\/radiol.2361040005"},{"key":"178","doi-asserted-by":"crossref","unstructured":"178. Ohno Y, Koyama H, Nogami M, et al. Dynamic oxygen-enhanced MRI versus quantitative CT: pulmonary functional loss assessment and clinical stage classification of smoking-related COPD. AJR Am J Roentgenol 2008; 190:W93\u201399.","DOI":"10.2214\/AJR.07.2511"},{"key":"179","doi-asserted-by":"crossref","unstructured":"179. Ohno Y, Iwasawa T, Seo JB, et al. Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:1095\u20131102.","DOI":"10.1164\/rccm.200709-1322OC"},{"key":"180","doi-asserted-by":"crossref","unstructured":"180. Ohno Y, Nishio M, Koyama H, et al. Oxygen-enhanced MRI, thin-section MDCT, and perfusion SPECT\/CT: comparison of clinical implications to patient care for lung volume reduction surgery. AJR Am J Roentgenol 2012; 199:794\u2013802.","DOI":"10.2214\/AJR.11.8250"},{"key":"181","doi-asserted-by":"crossref","unstructured":"181. Ohno Y, Koyama H, Yoshikawa T, et al. Comparison of capability of dynamic O<sub>2<\/sub>-enhanced MRI and quantitative thin-section MDCT to assess COPD in smokers. Eur J Radiol 2012; 81:1068\u20131075.","DOI":"10.1016\/j.ejrad.2011.02.004"},{"key":"182","doi-asserted-by":"crossref","unstructured":"182. Morgan AR, Parker GJ, Roberts C, et al. Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD. Eur J Radiol 2014; 83:2093\u20132101.","DOI":"10.1016\/j.ejrad.2014.08.004"},{"key":"183","doi-asserted-by":"crossref","unstructured":"183. Fuseya Y, Muro S, Sato S, et al. Complementary regional heterogeneity information from COPD patients obtained using oxygen-enhanced MRI and chest CT. PLoS One 2018; 13:e0203273.","DOI":"10.1371\/journal.pone.0203273"},{"key":"184","doi-asserted-by":"crossref","unstructured":"184. Ohno Y, Yui M, Yoshikawa T, et al. 3D oxygen-enhanced MRI at 3T MR system: comparison with thin-section CT of quantitative capability for pulmonary functional loss assessment and clinical stage classification of COPD in smokers. J Magn Reson Imaging 2021; 53:1042\u20131051.","DOI":"10.1002\/jmri.27441"},{"key":"185","doi-asserted-by":"crossref","unstructured":"185. Gutberlet M, Kaireit TF, Voskrebenzev A, et al. Free-breathing dynamic <sup>19<\/sup>F gas MR imaging for mapping of regional lung ventilation in patients with COPD. Radiology 2018; 286:1040\u20131051.","DOI":"10.1148\/radiol.2017170591"},{"key":"186","doi-asserted-by":"crossref","unstructured":"186. Gutberlet M, Kaireit TF, Voskrebenzev A, et al. Repeatability of regional lung ventilation quantification using fluorinated <sup>19<\/sup>F gas magnetic resonance imaging. Acad Radiol 2019; 26:395\u2013403.","DOI":"10.1016\/j.acra.2018.10.021"},{"key":"187","doi-asserted-by":"crossref","unstructured":"187. Amundsen T, Torheim G, Waage A, et al. Perfusion magnetic resonance imaging of the lung: characterization of pneumonia and chronic obstructive pulmonary disease. A feasibility study. J Magn Reson Imaging 2000; 12:224\u2013231.","DOI":"10.1002\/1522-2586(200008)12:2<224::AID-JMRI3>3.0.CO;2-E"},{"key":"188","doi-asserted-by":"crossref","unstructured":"188. Ohno Y, Hatabu H, Higashino T, et al. Dynamic perfusion MRI versus perfusion scintigraphy: prediction of postoperative lung function in patients with lung cancer. AJR Am J Roentgenol 2004; 182:73\u201378.","DOI":"10.2214\/ajr.182.1.1820073"},{"key":"189","doi-asserted-by":"crossref","unstructured":"189. Ohno Y, Koyama H, Nogami M, et al. Postoperative lung function in lung cancer patients: comparative analysis of predictive capability of MRI, CT, and SPECT. AJR Am J Roentgenol 2007; 189:400\u2013408.","DOI":"10.2214\/AJR.07.2084"},{"key":"190","doi-asserted-by":"crossref","unstructured":"190. Ohno Y, Koyama H, Nogami M, et al. State-of-the-art radiological techniques improve the assessment of postoperative lung function in patients with non-small cell lung cancer. Eur J Radiol 2011; 77:97\u2013104.","DOI":"10.1016\/j.ejrad.2009.07.024"},{"key":"191","doi-asserted-by":"crossref","unstructured":"191. Fan L, Xia Y, Guan Y, et al. Capability of differentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging. Eur Radiol 2013; 23:1234\u20131241.","DOI":"10.1007\/s00330-012-2729-2"},{"key":"192","doi-asserted-by":"crossref","unstructured":"192. Hueper K, Parikh MA, Prince MR, et al. Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study. Invest Radiol 2013; 48:223\u2013230.","DOI":"10.1097\/RLI.0b013e318281057d"},{"key":"193","doi-asserted-by":"crossref","unstructured":"193. Hueper K, Vogel-Claussen J, Parikh MA, et al. Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD Study. Am J Respir Crit Care Med 2015; 192:570\u2013580.","DOI":"10.1164\/rccm.201411-2120OC"},{"key":"194","doi-asserted-by":"crossref","unstructured":"194. Schoenfeld C, Cebotari S, Hinrichs J, et al. MR Imaging-derived Regional Pulmonary Parenchymal Perfusion and Cardiac Function for Monitoring Patients with Chronic Thromboembolic Pulmonary Hypertension before and after Pulmonary Endarterectomy. Radiology 2016; 279:925\u2013934.","DOI":"10.1148\/radiol.2015150765"},{"key":"195","doi-asserted-by":"crossref","unstructured":"195. Qing K, Tustison NJ, Mugler JP, et al. Probing Changes in Lung Physiology in COPD Using CT, Perfusion MRI, and Hyperpolarized Xenon-129 MRI. Acad Radiol 2019; 26:326\u2013334.","DOI":"10.1016\/j.acra.2018.05.025"},{"key":"196","doi-asserted-by":"crossref","unstructured":"196. Vogel-Claussen J, Sch\u00f6nfeld CO, Kaireit TF, et al. Effect of Indacaterol\/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial. Am J Respir Crit Care Med 2019; 199:1086\u20131096.","DOI":"10.1164\/rccm.201805-0995OC"},{"key":"197","doi-asserted-by":"crossref","unstructured":"197. Ogasawara N, Suga K, Zaki M, et al. Assessment of lung perfusion impairment in patients with pulmonary artery-occlusive and chronic obstructive pulmonary diseases with noncontrast electrocardiogram-gated fast-spin-echo perfusion MR imaging. J Magn Reson Imaging 2004; 20:601\u2013611.","DOI":"10.1002\/jmri.20150"},{"key":"198","doi-asserted-by":"crossref","unstructured":"198. Ohno Y, Seki S, Koyama H, et al. 3D ECG- and respiratory-gated non-contrast-enhanced (CE) perfusion MRI for postoperative lung function prediction in non-small-cell lung cancer patients: a comparison with thin-section quantitative computed tomography, dynamic CE-perfusion MRI, and perfusion scan. J Magn Reson Imaging 2015; 42:340\u2013353.","DOI":"10.1002\/jmri.24800"},{"key":"199","doi-asserted-by":"crossref","unstructured":"199. Voskrebenzev A, Gutberlet M, Kaireit TF, et al. Low-pass imaging of dynamic acquisitions (LIDA) with a group-oriented registration (GOREG) for proton MR imaging of lung ventilation. Magn Reson Med 2017; 78:1496\u20131505.","DOI":"10.1002\/mrm.26526"},{"key":"200","doi-asserted-by":"crossref","unstructured":"200. Voskrebenzev A, Gutberlet M, Klime\u0161 F, et al. Feasibility of quantitative regional ventilation and perfusion mapping with phase-resolved functional lung (PREFUL) MRI in healthy volunteers and COPD, CTEPH, and CF patients. Magn Reson Med 2018; 79:2306\u20132314.","DOI":"10.1002\/mrm.26893"},{"key":"201","doi-asserted-by":"crossref","unstructured":"201. Kaireit TF, Voskrebenzev A, Gutberlet M, et al. Comparison of quantitative regional perfusion-weighted phase resolved functional lung (PREFUL) MRI with dynamic gadolinium-enhanced regional pulmonary perfusion MRI in COPD patients. J Magn Reson Imaging 2019; 49:1122\u20131132.","DOI":"10.1002\/jmri.26342"},{"key":"202","doi-asserted-by":"crossref","unstructured":"202. Behrendt L, Voskrebenzev A, Klime\u0161 F, et al. Validation of automated perfusion-weighted phase-resolved functional lung (PREFUL)-MRI in patients with pulmonary diseases. J Magn Reson Imaging 2020; 52:103\u2013114.","DOI":"10.1002\/jmri.27027"},{"key":"203","doi-asserted-by":"crossref","unstructured":"203. Woolcock AJ. Epidemiology of chronic airways disease. Chest 1989; 96(3 Suppl):302S\u2013306S.","DOI":"10.1378\/chest.96.3_Supplement.302S"},{"key":"204","doi-asserted-by":"crossref","unstructured":"204. To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012; 12:204.","DOI":"10.1186\/1471-2458-12-204"},{"key":"205","doi-asserted-by":"crossref","unstructured":"205. Altes TA, Powers PL, Knight-Scott J, et al. Hyperpolarized 3He MR lung ventilation imaging in asthmatics: preliminary findings. J Magn Reson Imaging 2001; 13:378\u2013384.","DOI":"10.1002\/jmri.1054"},{"key":"206","doi-asserted-by":"crossref","unstructured":"206. Samee S, Altes T, Powers P, et al. Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol 2003; 111:1205\u20131211.","DOI":"10.1067\/mai.2003.1544"},{"key":"207","doi-asserted-by":"crossref","unstructured":"207. Haczku A, Emami K, Fischer MC, et al. Hyperpolarized <sup>3<\/sup>He MRI in asthma measurements of regional ventilation following allergic sensitization and challenge in mice\u2013preliminary results. Acad Radiol 2005; 12:1362\u20131370.","DOI":"10.1016\/j.acra.2005.08.027"},{"key":"208","doi-asserted-by":"crossref","unstructured":"208. de Lange EE, Altes TA, Patrie JT, et al. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest 2006; 130:1055\u20131062.","DOI":"10.1378\/chest.130.4.1055"},{"key":"209","doi-asserted-by":"crossref","unstructured":"209. de Lange EE, Altes TA, Patrie JT, et al. The variability of regional airflow obstruction within the lungs of patients with asthma: assessment with hyperpolarized helium-3 magnetic resonance imaging. J Allergy Clin Immunol 2007; 119:1072\u20131078.","DOI":"10.1016\/j.jaci.2006.12.659"},{"key":"210","doi-asserted-by":"crossref","unstructured":"210. Wang C, Altes TA, Mugler JP 3rd, et al. Assessment of the lung microstructure in patients with asthma using hyperpolarized 3He diffusion MRI at two time scales: comparison with healthy subjects and patients with COPD. J Magn Reson Imaging 2008; 28: 80\u201388.","DOI":"10.1002\/jmri.21408"},{"key":"211","doi-asserted-by":"crossref","unstructured":"211. de Lange EE, Altes TA, Patrie JT, et al. Changes in regional airflow obstruction over time in the lungs of patients with asthma: evaluation with 3He MR imaging. Radiology 2009; 250:567\u2013575.","DOI":"10.1148\/radiol.2502080188"},{"key":"212","doi-asserted-by":"crossref","unstructured":"212. Svenningsen S, Kirby M, Starr D, et al. Hyperpolarized <sup>3<\/sup>He and <sup>129<\/sup>Xe MRI: differences in asthma before bronchodilation. J Magn Reson Imaging 2013; 38:1521\u20131530.","DOI":"10.1002\/jmri.24111"},{"key":"213","doi-asserted-by":"crossref","unstructured":"213. Johansson MW, Kruger SJ, Schiebler ML, et al. Markers of vascular perturbation correlate with airway structural change in asthma. Am J Respir Crit Care Med 2013; 188:167\u2013178.","DOI":"10.1164\/rccm.201301-0185OC"},{"key":"214","doi-asserted-by":"crossref","unstructured":"214. Ebner L, He M, Virgincar RS, et al. Hyperpolarized <sup>129<\/sup>Xenon Magnetic Resonance Imaging to Quantify Regional Ventilation Differences in Mild to Moderate Asthma: A Prospective Comparison Between Semiautomated Ventilation Defect Percentage Calculation and Pulmonary Function Tests. Invest Radiol 2017; 52:120\u2013127.","DOI":"10.1097\/RLI.0000000000000322"},{"key":"215","doi-asserted-by":"crossref","unstructured":"215. Svenningsen S, Eddy RL, Lim HF, et al. Sputum Eosinophilia and Magnetic Resonance Imaging Ventilation Heterogeneity in Severe Asthma. Am J Respir Crit Care Med 2018; 197:876\u2013884.","DOI":"10.1164\/rccm.201709-1948OC"},{"key":"216","doi-asserted-by":"crossref","unstructured":"216. Eddy RL, Svenningsen S, Licskai C, et al. Hyperpolarized Helium 3 MRI in Mild-to-Moderate Asthma: Prediction of Postbronchodilator Reversibility. Radiology 2019; 293:212\u2013220.","DOI":"10.1148\/radiol.2019190420"},{"key":"217","doi-asserted-by":"crossref","unstructured":"217. Ohno Y, Koyama H, Matsumoto K, et al. Oxygen-enhanced MRI vs. quantitatively assessed thin-section CT: pulmonary functional loss assessment and clinical stage classification of asthmatics. Eur J Radiol 2011; 77:85\u201391.","DOI":"10.1016\/j.ejrad.2009.06.027"},{"key":"218","doi-asserted-by":"crossref","unstructured":"218. Ohno Y, Nishio M, Koyama H, et al. Asthma: comparison of dynamic oxygen-enhanced MR imaging and quantitative thin-section CT for evaluation of clinical treatment. Radiology 2014; 273:907\u2013916.","DOI":"10.1148\/radiol.14132660"},{"key":"219","doi-asserted-by":"crossref","unstructured":"219. Pinal-Fernandez I, Pineda-Sanchez V, Pallisa-Nu\u00f1ez E, et al. Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis. Clin Rheumatol 2016; 35:2339\u20132345.","DOI":"10.1007\/s10067-016-3267-0"},{"key":"220","doi-asserted-by":"crossref","unstructured":"220. Stadler A, Jakob PM, Griswold M, et al. T1 mapping of the entire lung parenchyma: Influence of respiratory phase and correlation to lung function test results in patients with diffuse lung disease. Magn Reson Med 2008; 59:96\u2013101.","DOI":"10.1002\/mrm.21446"},{"key":"221","doi-asserted-by":"crossref","unstructured":"221. Buzan MT, Eichinger M, Kreuter M, et al. T2 mapping of CT remodelling patterns in interstitial lung disease. Eur Radiol 2015; 25:3167\u20133174.","DOI":"10.1007\/s00330-015-3751-y"},{"key":"222","doi-asserted-by":"crossref","unstructured":"222. Ohno Y, Nishio M, Koyama H, et al. Oxygen-enhanced MRI for patients with connective tissue diseases: comparison with thin-section CT of capability for pulmonary functional and disease severity assessment. Eur J Radiol 2014; 83:391-397.","DOI":"10.1016\/j.ejrad.2013.11.001"},{"key":"223","doi-asserted-by":"crossref","unstructured":"223. Molinari F, Eichinger M, Risse F, Plathow C, Puderbach M, Ley S, Herth F, Bonomo L, Kauczor HU, Fink C. Navigator-triggered oxygen-enhanced MRI with simultaneous cardiac and respiratory synchronization for the assessment of interstitial lung disease. J Magn Reson Imaging 2007; 26:1523\u20131529.","DOI":"10.1002\/jmri.21043"},{"key":"224","doi-asserted-by":"crossref","unstructured":"224. Kaushik SS, Freeman MS, Yoon SW, et al. Measuring diffusion limitation with a perfusion-limited gas\u2013hyperpolarized 129Xe gas-transfer spectroscopy in patients with idiopathic pulmonary fibrosis. J Appl Physiol (1985) 2014; 117:577\u2013585.","DOI":"10.1152\/japplphysiol.00326.2014"},{"key":"225","doi-asserted-by":"crossref","unstructured":"225. Wang JM, Robertson SH, Wang Z, et al. Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis. Thorax 2018; 73:21\u201328.","DOI":"10.1136\/thoraxjnl-2017-210070"},{"key":"226","doi-asserted-by":"crossref","unstructured":"226. Weatherley ND, Stewart NJ, Chan HF, et al. Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF. Thorax 2019; 74:500\u2013502.","DOI":"10.1136\/thoraxjnl-2018-211851"},{"key":"227","doi-asserted-by":"crossref","unstructured":"227. Chan HF, Collier GJ, Weatherley ND, et al. Comparison of <i>in vivo<\/i> lung morphometry models from 3D multiple b-value 3 He and 129 Xe diffusion-weighted MRI. Magn Reson Med 2019; 81:2959\u20132971.","DOI":"10.1002\/mrm.27608"},{"key":"228","doi-asserted-by":"crossref","unstructured":"228. Yi CA, Lee KS, Han J, et al. 3-T MRI for differentiating inflammation- and fibrosis-predominant lesions of usual and nonspecific interstitial pneumonia: comparison study with pathologic correlation. AJR Am J Roentgenol 2008; 190:878\u2013885.","DOI":"10.2214\/AJR.07.2833"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/21\/1\/21_rev.2020-0184\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:40:24Z","timestamp":1715233224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/21\/1\/21_rev.2020-0184\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":228,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.rev.2020-0184","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"rev.2020-0184"}}